ChemicalBook--->CAS DataBase List--->960119-75-9

960119-75-9

960119-75-9 Structure

960119-75-9 Structure
IdentificationBack Directory
[Name]

1H-Benzimidazole, 1-ethyl-5-methyl-2-phenyl-
[CAS]

960119-75-9
[Synonyms]

1H-Benzimidazole, 1-ethyl-5-methyl-2-phenyl-
[Molecular Formula]

C16H16N2
[MOL File]

960119-75-9.mol
[Molecular Weight]

236.31
Chemical PropertiesBack Directory
[Melting point ]

90-92 °C
[Boiling point ]

405.3±38.0 °C(Predicted)
[density ]

1.08±0.1 g/cm3(Predicted)
[pka]

5.56±0.10(Predicted)
Hazard InformationBack Directory
[Description]

Fc11a-2 is a specific inhibitor of inflammasome assembly, targeting the NLRP3 inflammasome by interfering with the proximity-induced autocleavage of procaspase-1.
[Uses]

Fc 11a-2, a benzimidazole compound, is an orally active and potent NLRP3 inflammasome inhibitor. Fc 11a-2 restrains the formation of NLRP3 inflammasome by inhibiting activation of caspase-1 and thus the activation of IL-1b/IL-18. Fc 11a-2 prevents the development of Dextran sulfate sodium (DSS; HY-116282C)-induced murine experimental colitis[1][2][3].
[in vivo]

Fc 11a-2 (3-30 mg/kg; Orally; from day 1 to day 10) dose-dependently attenuates the loss of body weight and shortening of colon length induced by DSS[2].

Animal Model:C57BL/6 mice induced Colitis with 2.5% DSS[2]
Dosage:3, 10, 30 mg/kg
Administration:Orally; from day 1 to day 10
Result:Significantly attenuated the loss of body weight during the disease progression at 10 and 30 mg/kg.
The myeloperoxidase (MPO) activity in colons at 10 and 30 mg/kg was lower than that of the vehicle-treated group.
Significantly reduced the disease activity index, histopathologic scores and myeloperoxidase activity.
[References]

[1] Liangkun Pan, et al. Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives and Analogs Targeting the NLRP3 Inflammasome. Molecules. 2017 Jan 30;22(2):213. DOI:10.3390/molecules22020213
[2] Wen Liu, et al. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol. 2013 May 15;85(10):1504-12. DOI:10.1016/j.bcp.2013.03.008
[3] Biswadeep Das, et al. Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models. Molecules. 2021 Aug 18;26(16):4996. DOI:10.3390/molecules26164996
960119-75-9 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:960119-75-9 Related Product Information